Theodoros Mavridis

New Paper 📃 This review examines the role of RGMa in CNS pathologies such as stroke, Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, NMOSD, spinal cord injury and more. Congrats one more time to @v_tseriotis mdpi.com/3248562 #mdpiijms via @IJMS_MDPI

Excited to present our newly published study/meta-analysis on LAAO in patients with previous ICrH and/or CAA. Many thanks to my mentor @a_charidimou. Without his guidance this endeavor would not be possible. I also want to thank Dr Archontakis-Barakakis and Dr Chlorogiannis...

New Insights on Migraine Prevention! A fresh analysis comparing Gepants, anti-CGRP monoclonal antibodies, and traditional preventives reveals a clearer picture of benefit vs. risk in migraine care. Click the link below to learn more... tandfonline.com/doi/abs/10.108…

#MondayTip 📊Pooled INTERACT data ✅Intensive BP lowering improves recovery in ICH ⏱️When started <3h (cutoff: 2.6h)➡️reduces haematoma growth ☝️Greatest benefit in mild–moderate ICH (ICH score) 🚨Early treatment improves outcomes👉supports CODE-ICH systems & future trial design

Technical skills are important to influence the patient outcome. 👫 Strokecare is teamwork. Bastian Volbers from @inselgruppe demonstrating how simulation training can improve #stroketreatment. #EAN2025 #simulation #strokecare

I’m honoured to be running for IHS Trustee! I’m passionate about raising awareness and improving headache education, locally and globally. I’d be truly grateful for your support if you are eligible to vote (emails automatically sent) — and please feel free to share this post!

It was an honour to present our on ICH and/or CAA treated with LAAO work at #ESOC2025. 🔬 Special thanks to my mentor @a_charidimou and of course my colleagues, Paraschos Archontakis Barakakis and David Dimitris Chlorogiannis for the support. #VoiceOfStroke @ESOstroke

@a_charidimou kicks off #ESOC2025 @ESOstroke with a fine talk on application of diagnostic criteria in CAA

#ESOC2025 | What a Day 1! Full sessions, knowledge exchange & strong engagement across the #stroke community. Catch takeaways via ESOC TV Studio (live or on demand) ➡️ eso-stroke.org/esoc2025/ Enjoy your evening in #Helsinki #VoiceOfStroke #StrokeTwitter @OurFinland

Here's a review on some of the inherited thrombophilias that are frequently ordered as part of the hypercoagulability workup in arterial ischemic stroke. Read on to see which are recommended to be sent in the acute stroke workup, and which should not be ordered. #stroke #MedEd…

🩸🧠User friendly version of Boston Criteria v2.0 for Sporadic Cerebral Amyloid Angiopathy (CAA) #NeuroTwitter #Neurology #Neurosurgery #stroke #MedStudentTwitter #FOAMncc #MedTwitter #amyloidangiopathy #FOAMncc #neuroscience #brain #Alzheimers #Alzheimer #illustration…

Where does the swallow tail sign apply in clinical neurology? A systematic review by Tseriotis et al. explores its clinical utility in various neurological disorders. @v_tseriotis @TheodorosMavri2 loom.ly/LbXu5WM

#RCM - Vol. 23 No. 10 🗳️Systematic Review Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis @SanjanaNagraj @VipulGidwani30 @TheodorosMavri2 @GeorgeNtaios Full text: imrpress.com/journal/RCM/23…

⭕️🧠 CAA progression & neuropath staging (CAA=Cerebral Amyloid Angiopathy) Here is my take👇 which will try to unpack 🧵 in the coming days. ⛱️ CAA is not a single disease and is not uniform 🌂CAA does NOT invariably progress to bleeding as part of it's natural history, but…

⚡️🩸🧠 Practical framework for diagnosing Cerebral Amyloid Angiopathy-related inflammation (CAA-ri) We frequently discuss challenging CAA-ri cases with colleagues around the world. This framework summarizes key diagnostic features across the CAA-ri spectrum in a clinically…

Secondary TENSION RCT analysis: EVT works with good and poor collaterals in large core stroke. No significant difference. bit.ly/3Qydcfc Single-phase CTA scoring. @TENSIONstudy @CSI_Basel @MeyerL_MD @ikeafonso1 @FabianFlottmann @daigaole

Week 2 of the @MASStroke kicks off in Bern! Inspiring lectures, interactive courses, lively discussions—and plenty of networking and fun. Cheers to a great week!

What a privilege to host the next generation of European stroke leaders at the University of Bern. Lively discussions and curious minds stimulate us to continue our educational activities. I am very confident, that these future leaders will further decrease the burden of stroke.

🔎 #ESOBlog: Moyamoya Day 2024 Highlights Moyamoya Day 2024 raised awareness, shared research, and advanced clinical practices for this rare cerebrovascular disorder. Experts emphasised multidisciplinary collaboration to improve patient outcomes🔗 eso-stroke.org/event-report-m… #stroke